CDH11

(redirected from OB-cadherin)

CDH11

A gene on chromosome 16q21 that encodes a calcium-dependent cell–cell adhesion glycoprotein (cadherin), which is involved in regulating cell–cell adhesions, mobility and proliferation of epithelial cells. CDH11 is a so-called type-II (atypical) cadherin—which lacks a HAV cell adhesion recognition sequence specific to type-I cadherins—and is expressed in osteoblastic cell lines. It is upregulated during differentiation, suggesting a role during in bone development and maintenance.

Molecular pathology
Defects in CDH11 commonly occur in aneurysmal bone cysts and consist of a translocation t(16;17)(q22;p13) with USP6.
Mentioned in ?
References in periodicals archive ?
patent for compounds that inhibit cancer metastasis via OB-cadherin (cadherin-11) antagonism.
The abnormal presence of OB-cadherin in tumor cells has been found to be linked to cancer metastasizing to distant sites," explains Dr.
Laboratory studies at Georgetown University's Lombardi Cancer Centre have shown that Adherex OB-cadherin antagonists block cancer cell migration.
The classes of agents to be included under the agreement include peptide cadherin antagonist compounds for N-cadherin, E-cadherin, desmogleins, VE-cadherin and OB-cadherin, as well as Adherex's third generation small molecule, non-peptide cadherin antagonists.